- Ongoing, recruitingTherapeutic exploratory (Phase II)
J1I-MC-GZBU - A Phase 2b, Double-Blind Study to Investigate the Effect of LY3437943 on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
This study is looking at a new medicine called LY3437943 for people who are overweight or obese and have long-term kidney disease, whether or not they also have type 2 diabetes. We want to see if this medicine can help improve how well their kidneys work.
For: Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 DiabetesSpain · Italy - Ongoing, recruitingTherapeutic exploratory (Phase II)
A study to Assess the Effect of Vonafexor on Kidney Function in Subjects With Impaired Renal Function and Suspected MASH
This study is looking at a new medicine called Vonafexor for people with kidney problems and suspected MASH, a liver condition. It aims to see how well Vonafexor helps improve kidney function over 16 weeks and to understand its effects on the body.
For: Impaired renal function and suspected MASHGermany